XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenues:        
Total revenues $ 15,352 $ 14,595 $ 46,701 $ 47,045
Expenses:        
Cost of goods sold 3,591 7,099 11,432 15,446
Research and development 1,484 1,580 4,703 4,879
Selling, general and administrative 13,899 16,666 41,919 58,948
Asset impairment     1,889  
Loss (gain) on foreign currency translation 3,927 (3,807) 3,998 (4,495)
Total expenses 24,482 23,374 70,867 80,290
Loss from operations (9,130) (8,779) (24,166) (33,245)
Other (expense) income:        
Interest income 18 220 165 794
Interest expense on notes (1,057) (4,126) (3,212) (5,283)
Interest expense on promissory notes (1,318) (1,162) (3,858) (3,351)
Gain on extinguishment of debt   3,529   3,529
Other income (expense) 14 (52) 24 (84)
Total other expense (2,343) (1,591) (6,881) (4,395)
Loss before provision for income taxes (11,473) (10,370) (31,047) (37,640)
Benefit for income taxes 218 0 218 0
Net loss $ (11,255) $ (10,370) $ (30,829) $ (37,640)
Net loss per share - basic and diluted $ (0.05) $ (0.05) $ (0.14) $ (0.20)
Shares used to compute basic and diluted net loss per share 229,668 199,906 218,559 191,786
Commercial product sales        
Revenues:        
Total revenues $ 7,275 $ 6,402 $ 22,260 $ 17,543
Collaborations and services        
Revenues:        
Total revenues 8,077 8,193 24,441 29,502
Expenses:        
Cost of revenue $ 1,581 $ 1,836 $ 6,926 $ 5,512